[ Price : $8.95]
FDA approves a UCB expanded indication for Briviact (brivaracetam) tablets, oral solution, and injection to treat partial-onset se...[ Price : $8.95]
FDA approves an Anixa Biosciences IND for its CAR-T (Chimeric Antigen Receptor-T cell) therapy and its use in treating ovarian can...[ Price : $8.95]
FDA revises its guidance entitled Conduct of Clinical Trials of Medical Products During the Covid-19 Public Health Emergency.[ Price : $8.95]
FDA grants a de novo authorization to Zimmer Biomet and Canary Medical for their tibial extension for Persona IQ, the first smart ...[ Price : $8.95]
FDA grants Lantern Pharma an orphan drug designation for LP-184 and its use in treating glioblastoma multiforme and other malignan...[ Price : $8.95]
Federal Register notice: FDA announces that it has revoked the Emergency Use Authorization issued to Curative Inc. for its Curativ...[ Price : $8.95]
Federal Register notice: FDA makes available two draft device-specific guidance documents for the Safety and Performance Based Pat...[ Price : $8.95]
Roche withdraws its accelerated approval for Tecentriq (atezolizumab) in combination with chemotherapy for treating adults with un...